Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Providing Tools to Stemina for Metabolomic Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said yesterday that it is providing tools to Stemina Biomarker Discovery to accelerate its metabolomic research.

Agilent will provide Stemina with a 1290 Infinity UHPLC platform for the separation of stem cell metabolites, and a 6530 Q-TOF mass spec for the identification of metabolites. In addition, Agilent is providing Mass Profile Profession software for interpreting complex data generated from metabolomic research.

Based in Madison, Wis., Stemina uses metabolomic analysis of stem cells to discover biomarkers for use in drug screening and drug development.

In a statement, Gustavo Salem, vice president and general manager for Agilent's Biological Systems Division, said that metabolomics is a "major growth area" for the company, "and the innovative work being done at Stemina is the kind we like to support."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.